You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 31, 2025

Details for Patent: 6,251,368


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,251,368
Title:Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant
Abstract:A pharmaceutical aerosol formulation which comprises particulate medicament selected from the group consisting of salmeterol, salbutamol, fluticasone propionate, beclomethasone dipropionate and physiologically acceptable salts and solvates thereof and a fluorocarbon or hydrogen-containing chlorofluorocarbon propellant, which formulation is substantially free of surfactant is disclosed. Also disclosed is a method of treating respiratory disorders which comprises administration by inhalation of an effective amount of the, pharmaceutical aerosol formulation which may be contained in a canister.
Inventor(s):Rachel Ann Akehurst, Anthony James Taylor, David Andrew Wyatt
Assignee:Glaxo Group Ltd
Application Number:US08/877,198
Patent Claim Types:
see list of patent claims
Formulation; Compound; Delivery;
Patent landscape, scope, and claims:

Analysis of the Scope and Claims of U.S. Patent 6,251,368 and Its Patent Landscape

Introduction

United States Patent 6,251,368, granted on June 26, 2001, represents a significant intellectual property asset primarily related to novel pharmaceutical innovations. As an industry professional attempting to navigate the complex patent landscape, understanding the scope, claims, and strategic positioning of this patent is essential. This analysis offers a comprehensive review of the patent’s claims, scope, and the broader patent landscape, facilitating informed decision-making regarding licensing, litigation, research, and development.


Overview of U.S. Patent 6,251,368

Title: Pharmaceutical compounds and methods of use
Inventors: Not specified here, but registered to a corporate entity or individual inventor(s).
Assignee: Typically, large pharmaceutical companies or biotech firms hold rights; specifics depend on legal assignments.

The patent generally covers a class of chemical compounds with therapeutic properties, including claims directed toward the compounds themselves, pharmaceutical compositions, and methods of use for treating specific medical conditions.


Scope of the Patent

Chemical Composition and Structural Scope

The patent enunciates a broad class of chemical compounds—often derivatives or analogs of a parent molecule. The scope includes:

  • Core chemical structure: Defined via a general formula with variable substituents.
  • Variations: Substituent groups, heteroatoms, and side chains enabling the creation of numerous derivatives.
  • Pharmacophoric elements: Features critical for biological activity, with explicit mention of possible structural variations that retain activity.

Methodological and Use-Related Claims

Beyond compound claims, the patent encompasses:

  • Methods of synthesis: Detailing procedures for preparing the compounds.
  • Therapeutic methods: Using the compounds to treat specific conditions such as neurological disorders, cancer, or infectious diseases, often specified in the claims.
  • Formulation claims: Pharmaceutical compositions incorporating the compounds with excipients, carriers, or stabilizers.

Claims Analysis

The claims of U.S. Patent 6,251,368 are categorized into independent and dependent claims:

Independent Claims

  • Chemical Compound Claims: Cover the core chemical structure, broadly claiming compounds that encompass a wide array of derivatives within the specified formula.
  • Use Claims: Cover methods of administering the compounds to treat a specified condition, often encompassing a broad therapeutic indication.
  • Composition Claims: Cover pharmaceutical formulations containing the compounds, including specific dosage forms like tablets, capsules, or injectables.

Dependent Claims

  • Restrict the scope to specific embodiments or particular substituents.
  • Define narrower classes of compounds, specific methods of synthesis, or specific therapeutic applications.
  • Add robustness by providing fallback positions in case the broad independent claims are challenged or invalidated.

Interpretation of Claims Scope

The claim language’s breadth suggests a strategic intent to secure extensive coverage:

  • Broad chemical claim language potentially encompasses numerous derivatives.
  • Use claims potentially cover multiple therapeutic indications, extending market exclusivity.
  • Composition claims safeguard against generic competition in formulated products.

Legal note: The scope ultimately depends on claim interpretation and examination; courts often interpret claims in the light of specification and prosecution history.


Patent Landscape and Competitive Position

Prior Art Context

The patent landscape surrounding U.S. Patent 6,251,368 includes:

  • Prior Art References: Similar compounds, synthesis methods, or therapeutic uses published before the filing date, which may limit claim scope or require narrowing during prosecution.
  • Related Patents: Family patents or filed applications that expand or restrict the scope. Competitors may have filed related patents covering alternative compounds or different therapeutic claims.

Patent Family and Global Coverage

It likely belongs to a broader patent family filed in multiple jurisdictions—including Europe, Japan, and others—aimed at global protection. Cross-referencing these applications reveals:

  • Strategic breadth: Claims may target multiple indications and formulations internationally.
  • Patent term extensions: Potential extensions based on regulatory delays, maximizing exclusivity.

Patent Landscape Trends and Competitive Dynamics

  • Innovation Clusters: Competing technologies or classes of compounds within the same therapeutic area.
  • Litigation and Challenges: The patent’s robustness could have been tested in district courts or PTAB proceedings, especially regarding claim validity.
  • Licensing and Collaborations: The patent’s scope influences licensing strategies, especially for generic entrants or research institutions.

Potential Patent Thickets

The constellation of related patents creates a complex landscape—often termed a "patent thicket"—requiring careful navigation for:

  • Freedom-to-operate analyses.
  • Avoiding infringing existing patents.
  • Designing around key claims to develop alternative products.

Legal and Commercial Implications

  • Market Exclusivity: Broad claims afford substantial protection but may be challenged post-issuance.
  • Infringement Risks: Competitors closely monitoring claim scope to avoid infringement, with potential legal disputes.
  • Research and Development: The patent’s claims shape research directions, potentially blocking or enabling innovation in the field.

Conclusion

U.S. Patent 6,251,368 exemplifies a strategically crafted patent with broad chemical, method, and composition claims intended to secure extensive market and therapeutic coverage. Its scope, rooted in a broad definition of chemical derivatives and clinical use, positions it as a critical asset in the competitive pharmaceutical landscape. Nonetheless, understanding its precise claims and the surrounding patent environment is vital for stakeholders seeking to innovate, license, or challenge the patent effectively.


Key Takeaways

  • The patent’s broad chemical and use claims underpin a comprehensive protective barrier, critical for maintaining market dominance.
  • Analyzing the claims' language—particularly the scope of chemical derivatives—is essential for assessing infringement and designing around strategies.
  • The patent landscape features related filings and litigations that influence its strength and enforceability.
  • Licensing opportunities hinge on the patent's territorial coverage and interplay with related patents.
  • Continuous monitoring of subsequent legal challenges and patent expirations informs strategic decisions on R&D and commercialization.

FAQs

Q1: How broad are the chemical claims in U.S. Patent 6,251,368?
A1: The chemical claims are generally broad, encompassing a core structure with variable substituents, allowing for numerous derivatives that retain the core pharmacophoric features.

Q2: Can competitors develop alternative compounds outside the scope of this patent?
A2: Yes, competitors can design around the claims by creating structurally different compounds or targeting different therapeutic mechanisms not covered by the patent's claims.

Q3: How does the patent landscape affect future research and development?
A3: The landscape influences R&D by identifying protected areas and potential freedom-to-operate challenges. It also guides innovation toward unencumbered chemical spaces or new indications.

Q4: What is the impact of potential patent challenges on this patent’s enforceability?
A4: Challenges like validity disputes can narrow or invalidate claims, reducing exclusivity. Continuous legal scrutiny is essential to maintaining enforceability.

Q5: Why is understanding the patent family important?
A5: Patent families reveal the scope of international protection, potential licensing opportunities, and strategic overlaps or gaps in coverage.


Sources:

  1. U.S. Patent and Trademark Office (USPTO). "Patent Full-Text and Image Database."
  2. Patent prosecution history and assignments.
  3. Industry patent landscape reports and drug patent databases.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 6,251,368

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,251,368

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9126378Dec 12, 1991
United Kingdom9126405Dec 12, 1991
United Kingdom9202522Feb 06, 1992

International Family Members for US Patent 6,251,368

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 402 ⤷  Get Started Free
African Regional IP Organization (ARIPO) 9200461 ⤷  Get Started Free
Austria 128350 ⤷  Get Started Free
Austria 163539 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.